在心血管健康和疾病中的作用:药理和临床影响
Jingya Jiang1, Wanbing He2, Hui Huang1
1Department of Cardiology, Joint Laboratory of Guangdong-Hong Kong-Macao Universities for Nutritional Metabolism and Precise Prevention and Control of Major Chronic Diseases, The Eighth Affiliated Hospital of Sun Yat-sen University, Shenzhen, 518033, China.
European journal of pharmacology
|May 5, 2025
概括
对双相情感障碍的疗法具有双重的心血管效应. 虽然治疗剂量可能会保护心脏,但更高的剂量可能会造成伤害,因此需要仔细监测以确保安全使用.
科学领域:
- 心脏病学 心脏病学
- 精神病学是一个精神病学.
- 药理学 药理学是指药理学的学科.
背景情况:
- 是双相情感障碍 (BD) 的首要治疗方法.
- 它对心血管的影响是复杂的,并未完全理解.
- 证据表明,它既有有益的影响,也有有害影响.
研究的目的:
- 审查对心血管的直接和间接影响.
- 综合目前关于对心脏健康影响的证据.
- 为了澄清的治疗作用和不良心血管作用之间的平衡.
主要方法:
- 对现有文献进行系统审查.
- 对直接心脏影响的分析 (发育,增大,纤维化,线粒体,心律失常).
- 评估通过功能,代谢综合征和神经内分泌免疫通路的间接影响.
主要成果:
- 治疗性剂量可以通过抑制GSK-3β和调节Wnt/β-catenin信号传递来提供心脏保护.
- 超治疗性水平可以增加氧化应激,线粒体功能障碍和心律失常性.
- 临床研究表明,在治疗的BD患者中,心血管死亡率降低,可能超过代谢副作用.
结论:
- 对心血管的影响是剂量依赖的,多方面的.
- 关于长期结果和剂量特异性的证据存在矛盾.
- 需要进一步进行高质量的试验,以优化在BD治疗中的安全和有效使用.
相关概念视频
Adrenergic Antagonists: Pharmacological Actions of β-Receptor Blockers
479
β-receptor blockers significantly impact the cardiovascular system by counteracting catecholamine-induced sympathetic responses. These medications decrease heart rate, contractility, and cardiac output, potentially leading to cardiac depression, life-threatening bradycardia, and death. Therapeutically, β-blockers function as mild antihypertensives and are utilized in treating angina pectoris and cardiac arrhythmias. However, nonselective β-blockers inhibit β2-receptors in...
479
Antiarrhythmic Drugs: Class I Agents as Sodium Channel Blockers
1.1K
Class I antiarrhythmic drugs are used to treat various types of arrhythmias or irregular heart rhythms. These drugs block the sodium (Na+) channels in the cardiac cells, thereby affecting the movement of electrical impulses across the heart. Class I antiarrhythmic drugs are divided into three subgroups: Class IA, Class IB, and Class IC, each with distinct mechanisms of action and effects on the heart.
Class 1A Antiarrhythmic Drugs: These drugs work by moderately blocking sodium channels,...
Class 1A Antiarrhythmic Drugs: These drugs work by moderately blocking sodium channels,...
1.1K
Antianginal Drugs: Calcium Channel Blockers and Ranolazine
392
Angina pectoris, a primary symptom of ischemic heart disease, requires careful pharmacological interventions. In this context, calcium channel blockers (CCBs) and ranolazine have emerged as crucial pharmacotherapeutic agents, providing deep insights into the complexities of angina management.
CCBs, a diverse class that includes dihydropyridines (nifedipine) and diphenylalkylamines (verapamil and diltiazem), exert their effect by blocking calcium channels in cardiac and smooth muscle cells. This...
CCBs, a diverse class that includes dihydropyridines (nifedipine) and diphenylalkylamines (verapamil and diltiazem), exert their effect by blocking calcium channels in cardiac and smooth muscle cells. This...
392
Cardiovascular Drugs: Classification based on Therapeutic Indications
1.9K
Cardiovascular diseases, encompassing a range of conditions, can significantly affect the heart's operations and the overall circulatory system. These conditions impair the heart's ability to pump blood, leading to a deficit in oxygen supply to crucial organs. Anomalies in the heart's electrical system, known as arrhythmias, can cause heartbeats to accelerate or slow down. Usually, heart rates increase during physical activity and decrease while resting or sleeping. However,...
1.9K
Mania and Antimanic Drugs: Overview
103
Mania, a psychological condition characterized by elevated mood, increased energy, and reduced sleep need, is part of the bipolar disorder cycle. The exact cause of mania isn't entirely known, but it is thought to be a combination of genetic, environmental, and neurological factors. Bipolar disorder involves alternating manic and depressive episodes. Mood stabilizers like lithium, antipsychotics, and anticonvulsants help manage these episodes. Lithium carbonate is particularly effective as...
103
Psychoneuroimmunology: Cardiovascular Disease
18
Psychoneuroimmunology (PNI) is a multidisciplinary field that examines how psychological factors, particularly stress, interact with the immune system and impact physical health. Research in PNI has shown that chronic or traumatic stress can disrupt both the hypothalamic-pituitary-adrenal axis and the sympathetic nervous system. These disruptions contribute to serious health conditions, including cardiovascular diseases.
A key area of focus in PNI is the relationship between stress and coronary...
A key area of focus in PNI is the relationship between stress and coronary...
18


